Plain-English translation of NCT06747611 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Alopecia Areata research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
United States
Phase
Testing effectiveness
Sponsor
University of Minnesota
Collaborators
Columbia University
Enrollment target
~40 participants
Started
August 2025
Primary completion
March 2028
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
John Meisenheimer
University of Minnesota
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.